Kirchhoff-Institute for Physics, Heidelberg University , INF 227, 69120 Heidelberg, Germany.
Anal Chem. 2014 Nov 4;86(21):10511-4. doi: 10.1021/ac5028808. Epub 2014 Oct 22.
Today's minimally invasive biosensors are often based on chemical reagents and suffer from, e.g., oxygen dependence, toxic reaction products, excess analyte consumption, and/or degradation of the reagents. Here, we show the first successful analyte quantification by means of a minimally invasive sensor in vivo, which does not use chemical reactions. The concentration of glucose is determined continuously in vivo using transcutaneous, fiber-based mid-infrared laser spectroscopy. When comparing the infrared data measured in vivo with the 127 reference readings of glucose obtained in vitro, an overall standard deviation of 17.5% and a median of the absolute values of the relative deviations of 11.0% are achieved. The encouraging results open up the path toward a reagent-free long-term implant for the continuous surveillance of metabolites. In addition, the high sampling rate facilitates important research in body metabolism as well as its application outside the field of medicine such as real-time analyte sensing during fermentation.
今天的微创生物传感器通常基于化学试剂,并且存在例如氧气依赖性、有毒反应产物、过量分析物消耗和/或试剂降解等问题。在这里,我们展示了第一个成功的微创体内传感器的分析物定量,该传感器不使用化学反应。使用经皮、纤维型中红外激光光谱法连续在体内测定葡萄糖浓度。当将体内测量的红外数据与体外获得的 127 个葡萄糖参考读数进行比较时,实现了 17.5%的总体标准偏差和 11.0%的相对偏差绝对值中位数。令人鼓舞的结果为开发无试剂的长期植入式设备以用于连续监测代谢物开辟了道路。此外,高采样率有利于进行重要的代谢体研究及其在医学领域以外的应用,例如发酵过程中的实时分析物感测。